Omics-Insights: Your Weekly Genomics & Proteomics Digest

Welcome to our latest Omics newsletter, your portal for the freshest updates and innovations in genomics. This week's newsletter brings you the latest updates from the dynamic world of Omics. In this edition, we bring you the latest developments in the dynamic world of Omics, including key industry news, strategic collaborations, skill development essentials for finding a new job, & essential career tips for omics professionals.

This week's latest news in the field of Omics:

Parse Biosciences Expands Reach in Asia-Pacific Through Prisma Biotech Partnership

Parse Biosciences has entered into a distribution agreement with Prisma Biotech to expand the availability of its single-cell products across Taiwan and other Asia-Pacific regions. While financial specifics remain undisclosed, the deal ensures that Prisma will distribute Parse’s comprehensive single-cell portfolio, including reagent kits and data analysis solutions, to researchers in the region. Prisma CEO Kevin Tseng expressed enthusiasm about the partnership, noting that it will bring cutting-edge single-cell sequencing technology to a broader scientific community in Taiwan and beyond. This agreement is part of Parse Biosciences’ ongoing global expansion, with similar deals already in place across South America, India, Israel, Oceania, and South Korea.

PacBio Joins Forces with Singapore’s Precision Medicine Program for Genomic Research

Pacific Biosciences has announced a collaboration with Singapore’s National Precision Medicine (NPM) program to conduct large-scale population genomics studies using its Revio HiFi sequencing technology. This partnership, led by Precision Health Research, Singapore (PRECISE), will generate high-quality genomic data from a multi-thousand-sample cohort, contributing to diverse research areas such as cancer and rare disease studies. The collaboration will also enhance local sequencing infrastructure in Singapore, with the establishment of a centralized lab and the integration of Amazon Web Services for secure data processing. PacBio’s Revio system was selected for its capability to handle large-scale whole-genome sequencing projects, which are crucial for advancing precision medicine in Singapore’s diverse population.

Paige Unveils Groundbreaking AI Models for Cancer Diagnosis with Virchow2

Paige, a leader in clinical AI for cancer, has launched the second generation of its Virchow model, touted as the world's largest and most advanced AI models in clinical pathology. Developed in collaboration with Microsoft, the new models—Virchow2 and Virchow2G—are trained on a vast dataset of over 3 million pathology slides from 45 countries, offering unprecedented insights into cancer diagnosis and treatment. With 1.8 billion parameters, Virchow2G sets a new standard in AI training scale, promising to enhance precision medicine by enabling more accurate diagnostics and personalized care. Paige’s Chief Scientist, Dr. Thomas Fuchs, highlighted the potential of these models to revolutionize oncology by leveraging computational pathology to uncover new possibilities in cancer treatment.

Twist Bioscience Expands DNA Synthesis Capabilities with Longer Gene Fragments

Twist Bioscience Corporation has expanded its DNA synthesis offering by launching longer Gene Fragments, now available in lengths up to 5.0kb. This enhancement, made possible through Twist’s advanced silicon platform, allows researchers to incorporate more complex elements into their projects with fewer colonies needed for screening. The longer fragments also support applications in RNA therapeutic screening. CEO Emily M. Leproust emphasized the company's commitment to providing high-quality, scalable solutions to researchers at all stages, with the new Gene Fragments offering rapid turnaround times and a low error rate, which are critical for accelerating scientific discovery.

Integrated DNA Technologies Accelerates Genomics Research with Rapid Genes

Integrated DNA Technologies (IDT) has introduced Rapid Genes, a new addition to its synthetic biology portfolio designed to speed up high-throughput screening experiments for pharmaceutical researchers. Available in lengths from 125 to 2,000 base pairs, these next-generation sequencing-verified clonal genes can be delivered in as little as five business days. Alongside Rapid Genes, IDT is enhancing its existing gene synthesis offerings with expanded expression vector options and larger yield capabilities. IDT’s Vice President, Sandy Ottensmann, highlighted that these innovations are part of the company’s broader commitment to supporting the genomics research community with faster, more reliable tools to advance drug discovery and bioeconomy growth.

Current Live Roles at Kinetica:

Account Manager – Proteomics - Belgium

Account Manager – Proteomics - Switzerland

Account Manager – Proteomics - Boston

Business Development Manager - Proteomics Reagents - DACH

Business Development Manager - Proteomics Reagents - USA

Account Manager – Mid-Atlantic – Genomics reagents

Sales Specialist - NGS - Boston

Director of Product Management - LS Capital Equipment - Europe

Director of Applications Support - Genomics - West Coast

Operation Manager - LS Reagents - UK

Field Service Engineer - Imaging Equipment - Germany

Job Hunting Tips from an Omics Specialist Recruiter: Maximizing LinkedIn for Your Career

As an omics specialist, whether you're in genomics, proteomics, metabolomics, or any other 'omics' field, your LinkedIn profile is more than just a digital resume—it's a dynamic platform to showcase your expertise, connect with industry leaders, and land your dream job. Here’s how to get the best out of LinkedIn:

1. Optimize Your Profile with Relevant Keywords

Ensure your LinkedIn profile is filled with industry-specific keywords like "genomics," "proteomics," "CRISPR," or "mass spectrometry." Incorporate these terms into your headline, summary, and experience sections to increase your chances of appearing in recruiter searches.

2. Showcase Your Research and Achievements

Highlight your research, publications, and significant projects directly on your profile. Use the 'Featured' section to link to papers, presentations, or case studies that demonstrate your expertise and impact in the field.

3. Engage and Network Actively

Build meaningful connections with industry leaders, colleagues, and recruiters. Engage with posts, share your insights, and participate in discussions within relevant LinkedIn groups. Networking isn’t just about adding connections—it’s about building relationships.

4. Highlight Key Skills and Get Endorsements

Regularly update your skills section to reflect the latest trends and technologies in your field. Seek endorsements from colleagues and mentors to validate your expertise, making your profile more attractive to potential employers.

5. Craft a Strong, Compelling Summary

Your LinkedIn summary should succinctly convey your career journey, key achievements, and what you’re looking for in your next role. This is your chance to make a strong first impression, so make it engaging and reflective of your professional identity.

Focusing on these key areas will help you leverage LinkedIn to its full potential, connecting you with the right opportunities in the omics field.

Skill Development Essentials for Finding a New Job

Navigating the job market in the Life Science field requires not just a strong scientific background but also a robust set of professional skills. Here are key skill development essentials to focus on when seeking a new job, along with useful tools and websites to help you:

Technical Proficiency

Coursera: Enroll in courses from top universities on genomics, proteomics, bioinformatics, and more.

edX: Take courses in biotechnology, genomics, and other related fields.

Udacity: Participate in nanodegree programs that cover bioinformatics, machine learning, and data science.

Wrapping Up Another Omics-Insights:

Thank you for embarking on a journey into the dynamic world of Omics with Kinetica! Explore the latest genomics job opportunities, stay informed with industry news, and indulge in insightful blogs at www.kinetica.co.uk. Your curiosity drives my commitment to relevant content, and I'm here to provide insights that fuel your scientific endeavors. Feel free to reach out with any questions or feedback. Wishing you ongoing inspiration and discovery in your scientific pursuits. Until next week, may your experiments yield groundbreaking results, and may your Omics journey remain as fascinating as the science itself!